Our blogs explain health conditions and clinical research in a way that is easy to follow, so readers can feel more informed
Innovative Approaches in Ocular Drug Delivery
The estimated number of visually impaired people in the world is 285 million, with 39 million blind people. About 65 percent of visually impaired people and 82 percent of all blind people are 50 years or older. Four major blinding diseases...
Scientists Begin Testing Zika Vaccine in Humans
At FOMAT, vaccine development trials are work we understand deeply from our own experience conducting Phase 1 through Phase 4 studies across infectious disease indications. The speed with which the ZPIV Zika vaccine moved from animal studies to human trials in...
Nano-Decoy Lures Human Influenza A Virus to Its Doom
To infect its victims, influenza A heads for the lungs, where it latches onto sialic acid on the surface of cells. So researchers created the perfect decoy: A carefully constructed spherical nanoparticle coated in sialic acid lures the influenza A virus...
Can We Put a Price on Healthcare Innovation in Cancer?
Most media attention is awarded to cancer’s success stories – new treatment breakthroughs are celebrated as researchers (and journalists) search for an exciting new “cure” for cancer. But what happens after these innovations hit the news? And who is going to...
Genetic Analysis Debunks Purported Origin of 1980’s AIDS Epidemic
A new study exonerates Gaetan Dugas, a French-Canadian flight attendant long considered to be “HIV Patient Zero” in the 1980’s AIDS epidemic in the U.S. An international team of researchers hailing from the University of Arizona and University of Cambridge used...
Study Determines Efficacy of 2 Drugs to Treat a Form of Leukemia
Researchers have determined that two Phase 1 drugs (CX-4945 and JQ1) can work together to efficiently kill T-cell acute lymphoblastic leukemia cells while having minimal impact on normal blood cells, representing a significant advancement in T-Cell Leukemia Treatment. Although both drugs...
Minority Inclusion in Clinical Trials: When Diversity Priorities Show
Beyond the critical need for securing more study volunteers across the board in clinical trials, a popular concern in all areas of clinical research is achieving inclusion in clinical trials and promoting diversity. Whether in medical journals, popular press, social media,...
Colombian Pharmaceutical Market to See Strong Four Year Growth
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.1 billion by 2020, registering a compound annual growth rate (CAGR) of 7.3%, according to research and consulting firm GlobalData. The company’s latest report states that this substantial...
Tiny Gold Nanoparticles Could Help Develop New Pancreatic Cancer Therapy
A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease. In the U.S. this year, some 53,000 new cases will be diagnosed, and 42,000 patients will die of the disease, according...
Folinic Acid Could Help Children With Autism Communicate Better
Prescription doses of folinic acid, which is a reduced form of a B vitamin known as folate, could help improve the language and communication skills of children with autism spectrum disorder (ASD). These are the preliminary findings from a placebo-controlled trial...
Neuroscientists Identify Two Neuron Populations That Encode Happy or Fearful Memories
Our emotional state is governed partly by a tiny brain structure known as the amygdala, which is responsible for processing positive emotions such as happiness, and negative ones such as fear and anxiety. A new study from MIT finds that these...
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
At FOMAT, cardiovascular and metabolic health are among our most active areas of clinical research. Studies like this one are a reminder that the path to understanding cardiometabolic disease often starts with biomarker research and randomized controlled trials, exactly the kind...